Employees: 11-50
Total raised: $52.045143M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | NCL Techno... | ncltv.co.u... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 23.09.2020 | Series B | $52.045143... | - | cambridgen... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 23.09.2020 | SBC occupier Immune Regulation Limited raises £40.6 million ... | Series B round led by Morningside Ventures provides foundation to accelerate the drug development of... | cambridgen... |
| 23.09.2020 | SBC occupier Immune Regulation Limited raises £40.6 million ... | SBC occupier Immune Regulation Limited raises £40.6 million Series B equity financing 23-09-2020 S... | cambridgen... |
| 22.09.2020 | Immune Regulation Limited raises £40.6 million / $53.4 milli... | Series B round led by Morningside Ventures provides foundation to accelerate the drug development of... | ncltv.co.u... |
| 22.09.2020 | Immune Regulation Limited raises £40.6 million / $53.4 milli... | Series B round led by Morningside Ventures provides foundation to accelerate the drug development of... | nclim.co.u... |
| 21.09.2020 | Immune Regulation Raises £40.6M in Series B Equity Financing... | Immune Regulation Limited, a US and UK based clinical stage biotechnology company, closed a $40.6m S... | finsmes.co... |
| 21.09.2020 | Immune Regulation Limited: Immune Regulation Limited raises ... | DGAP-News: Immune Regulation Limited / Key word(s): Financing Immune Regulation Limited: Immune Reg... | marketscre... |